X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

IGSF8 is an innate immune checkpoint and cancer immunotherapy target.

Yulong Li | Xiangyang Wu | Caibin Sheng | Hailing Liu | Huizhu Liu | Yixuan Tang | Chao Liu | Qingyang Ding | Bin Xie | Xi Xiao | Rongbin Zheng | Quan Yu | Zengdan Guo | Jian Ma | Jin Wang | Jinghong Gao | Mei Tian | Wei Wang | Jia Zhou | Li Jiang | Mengmeng Gu | Sailing Shi | Michael Paull | Guanhua Yang | Wei Yang | Steve Landau | Xingfeng Bao | Xihao Hu | X Shirley Liu | Tengfei Xiao
Cell | 2024

Antigen presentation defects in tumors are prevalent mechanisms of adaptive immune evasion and resistance to cancer immunotherapy, whereas how tumors evade innate immunity is less clear. Using CRISPR screens, we discovered that IGSF8 expressed on tumors suppresses NK cell function by interacting with human KIR3DL2 and mouse Klra9 receptors on NK cells. IGSF8 is normally expressed in neuronal tissues and is not required for cell survival in vitro or in vivo. It is overexpressed and associated with low antigen presentation, low immune infiltration, and worse clinical outcomes in many tumors. An antibody that blocks IGSF8-NK receptor interaction enhances NK cell killing of malignant cells in vitro and upregulates antigen presentation, NK cell-mediated cytotoxicity, and T cell signaling in vivo. In syngeneic tumor models, anti-IGSF8 alone, or in combination with anti-PD1, inhibits tumor growth. Our results indicate that IGSF8 is an innate immune checkpoint that could be exploited as a therapeutic target.

Pubmed ID: 38657602 RIS Download

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


APC anti-mouse CD19 (antibody)

RRID:AB_313647

This monoclonal targets CD19

View all literature mentions

mouse anti-rabbit IgG-PE (antibody)

RRID:AB_628498

This monoclonal targets Rabbit n/a

View all literature mentions

InVivoPlus mouse IgG2a isotype control (antibody)

RRID:AB_1107771

This isotype control targets Unknown Specificity

View all literature mentions

InVivoPlus anti-mouse PD-1 (CD279) (antibody)

RRID:AB_2687796

This monoclonal targets PD-1 (CD279)

View all literature mentions

InVivoMab anti-mouse CD4 (antibody)

RRID:AB_10950382

This monoclonal targets CD4

View all literature mentions

InVivoMab anti-mouse CD8β (Lyt 3.2) (antibody)

RRID:AB_2687706

This monoclonal targets CD8β (Lyt 3.2)

View all literature mentions

InVivoPlus anti-mouse NK1.1 (antibody)

RRID:AB_1107737

This monoclonal targets NK1.1

View all literature mentions

FITC anti-mouse CD11c (antibody)

RRID:AB_313775

This monoclonal targets CD11c

View all literature mentions

PE anti-mouse CD11c (antibody)

RRID:AB_313777

This monoclonal targets CD11c

View all literature mentions

PE anti-mouse NK-1.1 (antibody)

RRID:AB_313395

This monoclonal targets NK-1.1

View all literature mentions

PerCP anti-mouse CD11c (antibody)

RRID:AB_2129643

This monoclonal targets CD11c

View all literature mentions

FITC anti-mouse CD3 (antibody)

RRID:AB_312661

This monoclonal targets CD3

View all literature mentions

PE/Cyanine7 anti-mouse F4/80 (antibody)

RRID:AB_893478

This monoclonal targets F4/80

View all literature mentions

FITC anti-mouse F4/80 (antibody)

RRID:AB_893502

This monoclonal targets F4/80

View all literature mentions

APC anti-mouse NK-1.1 (antibody)

RRID:AB_313396

This monoclonal targets NK-1.1

View all literature mentions

PE anti-mouse F4/80 (antibody)

RRID:AB_893486

This monoclonal targets F4/80

View all literature mentions

PE/Cyanine7 anti-mouse CD45 (antibody)

RRID:AB_2860726

This monoclonal targets CD45

View all literature mentions

Recombinant Anti-MHC class I + HLA A + HLA B antibody [EPR1394Y] (antibody)

RRID:AB_3073854

This recombinant monoclonal targets MHC class I + HLA A + HLA B

View all literature mentions

InVivoPlus human IgG1 isotype control (antibody)

RRID:AB_2687817

This isotype control targets Unknown Specificify

View all literature mentions

InVivoMab anti-human PD-1 (CD279) (antibody)

RRID:AB_10950318

This monoclonal targets PD-1 (CD279)

View all literature mentions

APC anti-human Perforin (antibody)

RRID:AB_2252843

This monoclonal targets Perforin

View all literature mentions

PE anti-human CD85j (ILT2) (antibody)

RRID:AB_2136385

This monoclonal targets CD85j

View all literature mentions

PE/Cyanine7 anti-human CD14 (antibody)

RRID:AB_2566714

This monoclonal targets CD14

View all literature mentions

APC anti-human CD107a (LAMP-1) (antibody)

RRID:AB_1279055

This monoclonal targets CD107a

View all literature mentions

FITC anti-human CD4 (antibody)

RRID:AB_314074

This monoclonal targets CD4

View all literature mentions

Anti-pan Cytokeratin (antibody)

RRID:AB_3086695

This monoclonal targets pan Cytokeratin

View all literature mentions

FITC anti-human IgG Fc (antibody)

RRID:AB_2721576

This monoclonal targets IgG Fc

View all literature mentions

APC anti-human IgG Fc (antibody)

RRID:AB_2565790

This monoclonal targets IgG Fc

View all literature mentions

PE anti-human IgG Fc (antibody)

RRID:AB_2565786

This monoclonal targets IgG Fc

View all literature mentions

Anti-IGSF8 Antibody (antibody)

RRID:AB_3086693

This polyclonal targets IGSF8

View all literature mentions

APC anti-human CD56 (NCAM) (antibody)

RRID:AB_2563913

This monoclonal targets CD56

View all literature mentions

PE anti-human CD3 (antibody)

RRID:AB_314044

This monoclonal targets CD3

View all literature mentions

PE anti-human CD56 (NCAM) (antibody)

RRID:AB_2563925

This monoclonal targets CD56

View all literature mentions

Human KIR3DL2/CD158k Antibody (antibody)

RRID:AB_3086694

This monoclonal targets KIR3DL2/CD158k

View all literature mentions

PE anti-human HLA-F (antibody)

RRID:AB_2650871

This monoclonal targets HLA-F

View all literature mentions

PE anti-human HLA-A,B,C (antibody)

RRID:AB_314874

This monoclonal targets HLA-A

View all literature mentions

PE anti-human HLA-G (antibody)

RRID:AB_1227710

This monoclonal targets HLA-G

View all literature mentions

CT26.WT (cell line)

RRID:CVCL_7256

Cell line CT26.WT is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

LL/2 (LLC1) (cell line)

RRID:CVCL_4358

Cell line LL/2 (LLC1) is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

B16-F10 (cell line)

RRID:CVCL_0159

Cell line B16-F10 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

NCI-H520 (cell line)

RRID:CVCL_1566

Cell line NCI-H520 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

EMT6 (cell line)

RRID:CVCL_1923

Cell line EMT6 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

A-375 (cell line)

RRID:CVCL_0132

Cell line A-375 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

VMM17 (cell line)

RRID:CVCL_S581

Cell line VMM17 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

K-562 (cell line)

RRID:CVCL_0004

Cell line K-562 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

AGS (cell line)

RRID:CVCL_0139

Cell line AGS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

COLO 205 (cell line)

RRID:CVCL_0218

Cell line COLO 205 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

FlowJo (software resource)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions

Kaluza (software resource)

RRID:SCR_016182

Flow cytometry analysis software.

View all literature mentions